1. Adler, C., Ketter, T., Frye, M.A., Yang, R., Bauer, M., 2014. Randomized, double-blind, placebo-controlled trial of adjunctive armodafinil (150 mg/day) in adults with bipolar I depression: Safety and primary efficacy findings. Presented at: 167th Annual Meeting of the American Psychiatric Association; May 3–7, 2014; New York, NY. Poster NR6-038.
2. A multinational study to pilot the modified Hypomania Checklist (mHCL) in the assessment of mixed depression;Altinbas;J. Affect. Disord.,2014
3. Acceleration and augmentation strategies for treating bipolar depression;Altshuler;Biol. Psychiatry,2003
4. Subsyndromal depression is associated with functional impairment in patients with bipolar disorder;Altshuler;J. Clin. Psychiatry,2002
5. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study;Amsterdam;Am. J. Psychiatry,2010